Modification of tumour blood flow using the hypertensive agent, angiotensin II
- 1 May 1993
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 67 (5), 981-988
- https://doi.org/10.1038/bjc.1993.180
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The relationship between regional variations in blood flow and histology in a transplanted rat fibrosarcomaBritish Journal of Cancer, 1990
- Blood flow and blood volume in a transplanted rat fibrosarcoma: comparison with various normal tissuesRadiotherapy and Oncology, 1990
- Winner of the 1988 Lund Science Award: Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinomain vivoInternational Journal of Hyperthermia, 1989
- Augmentation of anticancer effect with angiotensin II in intraarterial infusion chemotherapy for breast carcinomaCancer, 1988
- PERFUSION CHARACTERISTICS AND NOREPINEPHRINE REACTIVITY OF HUMAN RENAL-CARCINOMA1987
- VASCULAR REACTIVITY TO NOREPINEPHRINE OF 7,12-DIMETHYLBENZ(A)ANTHRACENE-INDUCED RAT MAMMARY-TUMORS AND NORMAL TISSUE AS STUDIED INVITRO1986
- Angiotensin-induced hypertension and chemotherapy for multiple lesions of malignant melanomaBritish Journal of Dermatology, 1985
- Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancerCancer, 1985
- MANIPULATION OF EXPERIMENTAL RAT AND RABBIT LIVER-TUMOR BLOOD-FLOW WITH ANGIOTENSIN-II1985
- INTERSTITIAL FLUID PRESSURE IN DMBA-INDUCED RAT MAMMARY-TUMORS1982